One example is the combination therapy using anti-PD-1 antibody together with gemcitabine, which enhanced the anticancer effect of the antibody through activation of macrophages and CD8+ T cells 11, 12, and, the enhancing effect by gemcitabine was independent of PD-L1 expression from the tumor cells 13. The gene discussed is PDCD1; the disease is neoplasm.